How factor VIIa works in hemophilia

This publication has 13 references indexed in Scilit:

• Influence of Factor VIIa and Phospholipids on Coagulation in “Acquired” Hemophilia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• Mechanism of factor VIIa–dependent coagulation in hemophilia blood
  Blood, 2002
• Response of Factor VIII and IX-Deficient Blood to Wild Type and High Membrane Affinity Mutant Factor VIIa in an In Vitro Whole Blood Clotting Assay: Possible Correlation to Clinical Outcome
  Thrombosis and Haemostasis, 2002
• Recombinant factor VIIa (NovoSeven®) as a hemostatic agent
  Seminars in Hematology, 2001
• Relationship between Factor VII Activity and Clinical Efficacy of Recombinant Factor VIIa Given by Continuous Infusion to Patients with Factor VIII Inhibitors
  Thrombosis and Haemostasis, 2001
• Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII
  Thrombosis and Haemostasis, 2001
• Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa
  Blood, 2000
• Evidence for Antiphospholipid Antibodies in Hemophilic Children with Factor VIII Inhibitors
  Thrombosis and Haemostasis, 1999
• Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.
  Proceedings of the National Academy of Sciences, 1986
• Isolation of functional human coagulation factor V by using a hybridoma antibody.
  Proceedings of the National Academy of Sciences, 1981